Skip to main content
Equibles

LKFT · Lakefront Biotherapeutics NV · Earnings Call Transcripts & Audio

Track LKFT — free

Use LKFT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LKFT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$26.71 -0.10 (-0.37%) At close · Sep 14
Rebalance outlook locked
Market Cap
$1.76B
Shares
65.48M

Lakefront Biotherapeutics NV Earnings Call Transcripts

Quarterly earnings calls for Lakefront Biotherapeutics NV (LKFT), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Conference
Investor event
2026-09-15
Lakefront Biotherapeutics NV (LKFT) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Lakefront Biotherapeutics NV (LKFT) Q1 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Lakefront Biotherapeutics NV (LKFT) Q4 2025 Earnings Call Transcript
Positive tone Cash position and capital allocation Gilead collaboration and OLCA Strategic transformation and pivot away from cell therapy
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Lakefront Biotherapeutics NV (LKFT) Q3 2025 Earnings Call Transcript
Cautious tone Gilead Collaboration Jyseleca Royalties Cell Therapy Wind-Down
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
Lakefront Biotherapeutics NV (LKFT) Q1 2025 Earnings Call Transcript
Positive tone SpinCo separation and leadership transition Cell therapy pipeline and clinical progress Partnerships and external collaborators
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-08
Lakefront Biotherapeutics NV (LKFT) Q4 2024 Earnings Call Transcript
Confident tone Cell therapy pipeline and CD19 CAR-T (GLPG5101 / ATALANTA) Planned separation into Galapagos and SpinCo Decentralized manufacturing platform (Cocoon / DMU)
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Lakefront Biotherapeutics NV (LKFT) Q3 2024 Earnings Call Transcript
Positive tone CAR-T cell therapy pipeline and decentralized manufacturing Clinical trial timelines and data readouts Pipeline expansion and discovery portfolio
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Lakefront Biotherapeutics NV (LKFT) Q2 2024 Earnings Call Transcript
Positive tone Cell therapy pipeline progress (5101, 5201) Adaptimmune collaboration / uza-cel BCMA / 5301 Parkinsonism safety event
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-28
Lakefront Biotherapeutics NV (LKFT) Q1 2024 Earnings Call Transcript
Positive tone Pipeline and R&D strategy Regulatory milestones (IND submissions) Cell therapy programs (5101, 5201, 5301)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Lakefront Biotherapeutics NV (LKFT) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Lakefront Biotherapeutics NV (LKFT) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Lakefront Biotherapeutics NV (LKFT) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Lakefront Biotherapeutics NV (LKFT) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Lakefront Biotherapeutics NV (LKFT) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Lakefront Biotherapeutics NV (LKFT) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Lakefront Biotherapeutics NV (LKFT) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Lakefront Biotherapeutics NV (LKFT) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Lakefront Biotherapeutics NV (LKFT) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Lakefront Biotherapeutics NV (LKFT) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Lakefront Biotherapeutics NV (LKFT) Q2 2021 Earnings Call Transcript
Revenue
139.77M EUR
▲ 40.4% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Lakefront Biotherapeutics NV (LKFT) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Lakefront Biotherapeutics NV (LKFT) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Lakefront Biotherapeutics NV (LKFT) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Lakefront Biotherapeutics NV (LKFT) Q2 2020 Earnings Call Transcript
Revenue
99.59M EUR
▲ 69.5% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Lakefront Biotherapeutics NV (LKFT) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1421876 CUSIP 36315X101 13F (30d) 1 filings 1 filers Visit website Investor relations